Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity - Wikidata - wikimedia - TriplyDB

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

http://www.wikidata.org/entity/Q24630261

about

The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13 Systemically dispersed innate IL-13-expressing cells in type 2 immunity Transcription factor RORα is critical for nuocyte development IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G The immune pathogenesis of scleroderma: context is everything The origin and role of innate lymphoid cells in the lung NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation Exercise as an Adjuvant Therapy for Hematopoietic Stem Cell Mobilization Innate cell communication kick-starts pathogen-specific immunity The IL-1 cytokine family and its role in inflammation and fibrosis in the lung Regulation of Th2 Cell Immunity by Dendritic Cells Type 2 innate lymphoid cells: at the cross-roads in allergic asthma Interleukin (IL)-25: Pleiotropic roles in asthma Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis The role of IL-33 and mast cells in allergy and inflammation Transcriptional Regulatory Network for the Development of Innate Lymphoid Cells Maintenance of Immune Homeostasis through ILC/T Cell Interactions Innate lymphoid cells in graft-versus-host disease Innate immunity in disease I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis Regulation of type 2 immunity to helminths by mast cells Role of innate immunity in the pathogenesis of chronic rhinosinusitis: progress and new avenues IL-4 and IL-13 signaling in allergic airway disease Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time Development and function of group 2 innate lymphoid cells Regulation of the adaptive immune system by innate lymphoid cells Insights into the initiation of type 2 immune responses The role of type 2 innate lymphoid cells in asthma Innate receptors and cellular defense against pulmonary infections Role of group 3 innate lymphoid cells in antibody production Protection and pathology during parasite infection: IL-10 strikes the balance Transcriptional control of innate lymphoid cells Cytokine-induced cytokine production by conventional and innate lymphoid cells The cell biology of asthma Innate lymphocyte cells in asthma phenotypes Innate lymphoid cells in the airways Group 2 innate lymphoid cells in the lung Hematopoietic progenitor cells are innate Th2 cytokine-producing cells

P2860

Q24563655-F45100E1-40C8-4C1F-8865-D4AB3BB77498 Q24594675-632ABBFC-A1C8-4CC6-8553-F039EC2BA76E Q24610206-7C17421D-E0D0-4DB3-ABDD-6B655A74D6C4 Q24623563-FBDE6E81-9895-44D9-B0CD-ECB744E935D5 Q24629126-1FDA90CA-064B-418A-99B6-72383E8BB688 Q24633495-EAE39C3A-B6A4-4A1E-BCA0-853ABADEE45F Q24633658-F3C3E74E-73F1-4616-A697-2D2FDE247B2E Q26740079-20ADD540-EA68-47CD-8EE2-377408026E44 Q26744632-84C5F1E0-1F57-4EE6-911F-502179D827F9 Q26749247-067A8E7C-38C7-4EBA-B6AE-87612F166B36 Q26752790-7CEF0659-AB0E-481D-912E-D016C6493B88 Q26752849-3CDD780F-2A01-486D-AC47-F24ED8B5E520 Q26764869-486E6769-7D75-4CD5-8A2A-7A4E95D66539 Q26766464-D6101571-E9D3-4850-B33D-55077F9D8CC9 Q26772165-2ADEDCF1-9CE6-415F-B06D-22A2643C2732 Q26774652-E215932F-79D2-45E0-ADA3-882559D68B9A Q26783420-1F5BBB61-A7BA-4C1F-BAEF-F885B6EFFE98 Q26785671-CD2AA151-7E0A-4DAB-A6FF-30605557C9E3 Q26796071-AB380CA1-0927-4026-8267-769843C5A457 Q26801315-370A38C1-95EC-4C61-99AB-5FFC3DD3F824 Q26825435-94498EA2-F059-4219-91CC-7046812B3B7F Q26827479-366B8095-48BC-453E-BE18-D0282BF67C05 Q26828558-CFFF76AE-32A2-4EDB-B987-F9A0CE9C6F75 Q26830200-B21E3CE7-B1B9-4B89-9DEA-656EA33E02F7 Q26859510-64AF9502-F80F-42B1-AC10-01A174FA8D64 Q26861554-E3F82CC6-970E-4ED8-9C6A-A57B2668606B Q26862916-711DC114-5605-42BC-A676-6BE2C79CA9CE Q26864694-724F1CD9-1213-4584-A950-201F6CE0B220 Q26865705-2BDD3D40-B613-4137-BB0C-149F23FA3B8A Q26995991-BF257DC3-601D-48FE-AD39-621B5D62A90F Q26996036-8695CA36-0074-4A8C-B9A8-2529D0A4407B Q27001687-A465D1F4-65AE-459F-8303-649EE25AAA5C Q27005837-382DE6C4-FA7D-4ED2-8ECE-29E7FEA60284 Q27005868-BA0012C3-3BB4-4956-B326-FCEC46E92AB1 Q27007655-84C9AB63-7F34-4907-97E7-1CABFEEAD1CB Q27009449-9FE3BE9A-FC55-47F8-86FC-FF4D7B3234B3 Q27010139-BAD202EE-0976-4CDE-B39F-9651EFB45235 Q27012728-E1FF82EC-FF2F-4B38-959D-1DF721F8BAC9 Q27021302-ACCF31AC-D98C-48C9-8450-EF5C17EE0D2E Q27021587-4B4FDC52-3170-4D39-8903-AD10FF0C8D17

P2860

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

http://www.wikidata.org/entity/Q24630261

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@ast

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@en

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@nl

type

label

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@ast

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@en

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@nl

prefLabel

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@ast

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@en

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@nl

P1433

Q24630261-C39ED007-50E8-47B4-ABC0-49CB02693A64

P1476

Q24630261-42F3F8BC-F3A3-4E8D-A389-77FCEAE57885

P2093

Q24630261-160845CF-4676-44E0-8368-6F90D61FC419

Q24630261-30608689-8B5E-410D-BBE6-C07259741B4D

Q24630261-576D722D-64CF-4E59-A5FB-6CAB17CA8E1B

Q24630261-96FFB670-CCF9-463B-8F46-82AB9B183830

Q24630261-A1A34967-9E9B-46CE-9A98-F4F8BC095C94

Q24630261-A2F1AEED-30F3-4527-A829-96E2ABDF5C5F

Q24630261-C0F26E63-7520-41D6-82A6-F7E28E5C589C

Q24630261-FFFEAD89-FCC7-4553-9D55-5D7E35367766

P2860

Q24630261-11A9048F-480B-4EAD-BA43-20986A847C88

Q24630261-28B97D94-1880-4771-B23D-CD278C2A15DB

Q24630261-2E9C2BF4-7273-4F9A-A96B-B0A37E6FDF7C

Q24630261-3028F190-99B3-4643-8513-C7767AFD7BF8

Q24630261-5149132B-6A9D-472C-96EC-5DAC5E572498

Q24630261-575CCE96-80D6-40DF-A281-A7EA3556ADFE

Q24630261-672C0BB1-ABB1-444D-80D1-00D37C3F41BB

Q24630261-67CE8AE8-4A1B-4E47-9770-CABEC3411BAC

Q24630261-7AECA221-CAC5-493F-B0B5-37E121975263

Q24630261-8662D73F-E40C-4599-B51E-9807D53CF4EA

P2888

Q24630261-8A30A726-CC6F-469C-94E2-231D4EE216F6

P304

Q24630261-343D2979-FE18-47F7-BD7D-ADCF6D985020

P31

Q24630261-14139E22-C1B9-4567-AFA6-11ED61CBFE4E

P3181

Q24630261-1A6BD503-3CBB-46BE-8D5F-A236A86E0476

P356

Q24630261-DBD19D9F-AA20-4224-AAB1-59BB2B6A7A33

P407

Q24630261-272D3BAF-E5C1-436C-9C6A-3CE4AF76BEDF

P433

Q24630261-93B6FAA5-B5D4-475F-AD7D-BFBE76619C1A

P478

Q24630261-F1425FCA-215E-48B2-B89B-B623BFD8239C

P50

Q24630261-9421B6FF-82F6-45C3-9F84-9542F589E147

Q24630261-94D004AF-C1D5-457C-9CE4-F88D29D89912

Q24630261-B1A7C138-2FFD-488F-A6CA-E5CE6F4139E3

Q24630261-DD36BAAA-76AB-454A-AF1A-BBD5FCCD4CAE

P577

Q24630261-B9E229AF-7F9B-4497-8770-74AB5BFD10B8

P5875

Q24630261-B46A3114-FD5E-4BD5-83F4-5BBF4CBEFF7D

P6179

Q24630261-B7F4F417-5CBB-48FB-9F72-A5B44D70DD67

P698

Q24630261-BEDB7738-F846-4D3C-8017-F41962E5DD94

P921

Q24630261-395EECF1-2737-4065-9EC1-4E86CBC2490E

P932

Q24630261-16C28F85-1B92-41A0-86A4-95DE9FC1B093

P3181

P356

P1433

P1476

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

@en

P2093

Agustin Bellosi

http://www.w3.org/2001/XMLSchema#string

Christine Bucks

http://www.w3.org/2001/XMLSchema#string

Colleen M Kane

http://www.w3.org/2001/XMLSchema#string

Helen E Jolin

http://www.w3.org/2001/XMLSchema#string

Maria Daly

http://www.w3.org/2001/XMLSchema#string

Richard Pannell

http://www.w3.org/2001/XMLSchema#string

See Heng Wong

http://www.w3.org/2001/XMLSchema#string

Theresa K A Langford

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

Simple and highly efficient BAC recombineering using galK selection

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

A highly efficient recombineering-based method for generating conditional knockout mutations

Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis.

The role of basophils in helminth infection.

The role of T lymphocytes in the pathogenesis of asthma.

Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system.

Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite

Treatment strategies for allergy and asthma.

P2888

P304

1367-1370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

349072

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE08900

http://www.w3.org/2001/XMLSchema#string

P407

P433

7293

http://www.w3.org/2001/XMLSchema#string

P478

464

http://www.w3.org/2001/XMLSchema#string

P50

Andrew N. J. McKenzie

Daniel R. Neill

Padraic G. Fallon

P577

2010-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41722326

http://www.w3.org/2001/XMLSchema#string

P6179

1048663015

http://www.w3.org/2001/XMLSchema#string

P698

20200518

http://www.w3.org/2001/XMLSchema#string

P921

type 2 immune response

P932

2862165

http://www.w3.org/2001/XMLSchema#string